Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Recovery and rechallenge after the neuroleptic malignant synorome.

Chopra MP, Raguram R.

Indian J Psychiatry. 2001 Jan;43(1):41-5.

2.

Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.

Wells AJ, Sommi RW, Crismon ML.

Drug Intell Clin Pharm. 1988 Jun;22(6):475-80. Review.

PMID:
2899492
3.

Neuroleptic Malignant Syndrome.

Pileggi DJ, Cook AM.

Ann Pharmacother. 2016 Nov;50(11):973-981. doi: 10.1177/1060028016657553. Epub 2016 Jul 19. Review.

PMID:
27423483
4.

The treatment and management of neuroleptic malignant syndrome.

Gratz SS, Levinson DF, Simpson GM.

Prog Neuropsychopharmacol Biol Psychiatry. 1992 Jul;16(4):425-43. Review.

PMID:
1641490
5.

[Neuroleptic malignant syndrome from treatment with antidepressives].

Heinemann F, Assion HJ, Laux G.

Fortschr Neurol Psychiatr. 1997 May;65(5):208-13. Review. German.

PMID:
9235312
6.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
7.

[Neuroleptic malignant syndrome. Case reports].

Berardi D, Troia M, Veronesi L, Ferrari G.

Minerva Psichiatr. 1994 Dec;35(4):199-219. Review. Italian.

PMID:
7861943
8.

[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].

Kimura T, Yoshida H.

No To Shinkei. 1994 Sep;46(9):859-62. Review. Japanese.

PMID:
7999444
9.
10.

Recurrence of neuroleptic malignant syndrome.

Susman VL, Addonizio G.

J Nerv Ment Dis. 1988 Apr;176(4):234-41. Review.

PMID:
2895164
11.

Aetiology and treatment of neuroleptic malignant syndrome.

Harpe C, Stoudemire A.

Med Toxicol. 1987 May-Jun;2(3):166-76. Review.

PMID:
3298921
12.

The neuroleptic malignant syndrome: agent and host interaction.

Shalev A, Munitz H.

Acta Psychiatr Scand. 1986 Apr;73(4):337-47. Review.

PMID:
2873715
13.

Neuroleptic malignant syndrome.

Kornhuber J, Weller M.

Curr Opin Neurol. 1994 Aug;7(4):353-7. Review.

PMID:
7952245
14.

Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.

Perry PJ, Wilborn CA.

Ann Clin Psychiatry. 2012 May;24(2):155-62. Review.

PMID:
22563571
15.

[Studies of risk factors and preventive care for neuroleptic malignant syndrome].

Tanii H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Nov;26(5-6):177-81. Review. Japanese.

PMID:
17240842
16.

[Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].

Andreassen MD, Pedersen S.

Ugeskr Laeger. 2000 Mar 6;162(10):1366-70. Review. Danish.

PMID:
10745673
17.

Neuroleptic malignant syndrome: a review and report of six cases.

Kasantikul D, Kanchanatawan B.

J Med Assoc Thai. 2006 Dec;89(12):2155-60. Review.

PMID:
17214072
18.

Neuroleptic malignant syndrome under treatment with antidepressants? A critical review.

Assion HJ, Heinemann F, Laux G.

Eur Arch Psychiatry Clin Neurosci. 1998;248(5):231-9. Review.

PMID:
9840369
19.

[Neuroleptic malignant syndrome].

Murak E.

Psychiatr Pol. 1995 May-Jun;29(3):349-58. Review. Polish.

PMID:
7652088
20.

Neuroleptic malignant syndrome.

Moscovich M, Nóvak FT, Fernandes AF, Bruch T, Tomelin T, Nóvak EM, Munhoz RP, Teive HA.

Arq Neuropsiquiatr. 2011 Oct;69(5):751-5. Review.

Supplemental Content

Support Center